This article is more than 5 years old. Information may no longer be current.

FDA clears pattern scanning laser trabeculoplasty for Pascal laser

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The Pascal laser has received FDA clearance to offer pattern scanning laser trabeculoplasty, according to a Topcon press release.

Pattern scanning laser trabeculoplasty (PSLT) is a laser treatment for reducing IOP in open-angle glaucoma. It provides a “minimally traumatic computer-guided treatment that applies a sequence of patterns onto the trabecular meshwork,” the release said.

“Globally, we’ve seen success with the Streamline’ PSLT application and believe glaucoma specialists and comprehensive ophthalmologists in the United States will find this technology a useful addition to their treatment armamentarium,” Robert Gibson, Topcon vice president, eye care global marketing, said in the release.